Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunological tolerance].

Hisanori Kosuge1, Mitsuaki Isobe

  • 1Department of Cardiovascular Medicine, Tokyo Medical and Dental University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypertrophic Cardiomyopathy and Sudden Cardiac Arrest Associated with a PSEN1 Variant: A Case Report.

Internal medicine (Tokyo, Japan)·2026
Same author

Diagnostic and prognostic value of T2 mapping in cardiac sarcoidosis.

International journal of cardiology. Heart & vasculature·2026
Same author

Subclinical myocardial changes in idiopathic premature ventricular contractions: insights from cardiac magnetic resonance imaging.

Frontiers in cardiovascular medicine·2026
Same author

Liver native T1 mapping for predicting cardiovascular outcomes across stages of heart failure.

Clinical research in cardiology : official journal of the German Cardiac Society·2025
Same author

Coronary Microvascular Dysfunction and Adverse Outcomes in the Spectrum of Dilated Cardiomyopathy.

International heart journal·2025
Same author

Clinical characteristics of female Fabry disease patients with hypertrophic cardiomyopathy with mid-ventricular obstruction.

Molecular genetics and metabolism reports·2025
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

New immunosuppressive drugs improve early transplant survival, but graft rejection remains a challenge. Targeting costimulatory pathways is key to inducing donor-specific tolerance and enhancing long-term organ transplant success.

Area of Science:

  • Immunology
  • Transplantation Biology
  • Cellular Signaling

Context:

  • Organ transplantation offers a life-saving solution for end-stage organ failure.
  • Despite advancements in immunosuppressive agents, chronic allograft rejection remains a significant barrier to long-term graft survival.
  • Donor-specific tolerance is critical for overcoming rejection and ensuring the longevity of transplanted organs.

Purpose:

  • To highlight the critical role of costimulatory pathways in T cell activation.
  • To identify costimulatory pathways as potential therapeutic targets for inducing donor-specific tolerance.
  • To underscore the importance of these pathways in improving long-term outcomes in organ transplantation.

Summary:

  • New immunosuppressive agents have enhanced early survival rates in organ transplant recipients.

Related Experiment Videos

  • Chronic allograft rejection continues to compromise long-term graft survival.
  • Costimulatory pathways are essential regulators of T cell activation and are promising targets for inducing donor-specific tolerance.

    • Impact:

    • Inducing donor-specific tolerance through modulation of costimulatory pathways can significantly improve long-term organ transplant survival.
    • This research opens avenues for developing novel therapeutic strategies to combat chronic allograft rejection.
    • Ultimately, this work aims to enhance the quality of life and survival rates for organ transplant recipients worldwide.